Our results indicate that LD among tightly linked marker should be examined, especially in the fine-mapping stage where strong LD is likely to exist between the markers. Markers that are in strong LD should not be used together for linkage analysis in order to avoid possible false positives. An alternative approach is to modify current linkage programs to allow for LD so that all marker information can be used in the search for a disease-related region.
